PEG-IFN-alpha-2b therapy in BCR-ABL-negative myeloproliferative disorders: final result of a phase 2 study.

Abstract:

BACKGROUND:Interferon-alpha (IFN-alpha) has shown significant activity in the treatment of BCR-ABL-negative myeloproliferative disorders (MPDs), particularly essential thrombocythemia (ET) and polycythemia vera (PV). PEG-IFN-alpha-2b is a pegylated IFN-alpha-2b with a significant advantage over nonpegylated form in that it is administered once a week. METHODS:Thirty-eight patients with BCR-ABL-negative MPDs were treated with PEG-IFN-alpha-2b, given subcutaneously weekly, at the starting dose of 3 microg/kg/wk for the first 14 patients and then 2 microg/kg/wk for the next 24 patients, with intent to treat patients as long as they benefited from the therapy. RESULTS:Median age was 54 years. Patient diagnoses were: 13 (34%) ET; 11 (29%) primary myelofibrosis (PMF); 5 (13%) BCR-ABL-negative chronic myeloid leukemia (CML); 4 (10.5%) hypereosinophilic syndrome (HES); 4 (10.5%) PV; and 1 (3%) unclassified myeloproliferative disease (uMPD). Recorded grade 3-4 toxicities were related to fatigue, myelosuppression, and musculoskeletal pain. Ten (26%) patients stopped treatment because of toxicity. Thirteen (34%) patients achieved a complete remission, and 4 (11%) achieved a partial response. Only 1 patient with PMF responded. Median time to response was 5 months. Median duration of response was 20 months. Three patients had a sustained response for >24 months. CONCLUSIONS:PEG-IFN-alpha-2b, with proper dose modifications, is effective in controlling disease in a significant proportion of BCR-ABL-negative MPD patients, particularly ET and PV. However, toxicities encountered with PEG-IFN-alpha-2b therapy are similar to those obtained with conventional IFN-alpha, thus limiting the duration of therapy.

journal_name

Cancer

journal_title

Cancer

authors

Jabbour E,Kantarjian H,Cortes J,Thomas D,Garcia-Manero G,Ferrajoli A,Faderl S,Richie MA,Beran M,Giles F,Verstovsek S

doi

10.1002/cncr.23018

subject

Has Abstract

pub_date

2007-11-01 00:00:00

pages

2012-8

issue

9

eissn

0008-543X

issn

1097-0142

journal_volume

110

pub_type

杂志文章

相关文献

CANCER文献大全
  • Serum and urine beta-2-microglobulin in hemophagocytic syndrome.

    abstract:BACKGROUND:Previous reports suggesting a correlation between lymphoproliferative disease and serum levels of beta-2-microglobulin (beta-2M) and in vitro data indicating a role of cytokines in the production of beta-2M prompted a study of serum and urine beta-2M concentration in patients with hemophagocytic syndrome (HP...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950401)75:7<1700::aid-cncr2820

    authors: Hibi S,Ikushima S,Fujiwara F,Hashida T,Tsunamoto K,Todo S,Imashuku S

    更新日期:1995-04-01 00:00:00

  • Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

    abstract:BACKGROUND:Allogeneic hematopoietic cell transplantation (HCT) is a curative therapy for patients with acute myeloid leukemia (AML). However, post-HCT relapse and regimen-related toxicity remain significant barriers to long-term survival. In recent years, new conditioning regimens have been explored to improve transpla...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30646

    authors: Nagler A,Labopin M,Beelen D,Ciceri F,Volin L,Shimoni A,Foá R,Milpied N,Peccatori J,Polge E,Mailhol A,Mohty M,Savani BN

    更新日期:2017-07-15 00:00:00

  • Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer.

    abstract:BACKGROUND:Data suggest that vitamin D plays a role in the treatment and prevention of prostate cancer. The combination of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) plus dexamethasone was studied based on evidence that dexamethasone potentiates the antitumor effects of calcitriol and ameliorates hyp...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21890

    authors: Trump DL,Potter DM,Muindi J,Brufsky A,Johnson CS

    更新日期:2006-05-15 00:00:00

  • Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy.

    abstract:BACKGROUND:The purpose of the study was to determine the utility of quantitation of the extracellular domain (ECD) of the HER-2/neu receptor in the serum for predicting response to treatment in patients with primary breast cancer receiving neoadjuvant therapy. METHODS:HER-2/neu ECD was measured in sera obtained from 3...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.22418

    authors: Mazouni C,Hall A,Broglio K,Fritsche H,Andre F,Esteva FJ,Hortobagyi GN,Buzdar AU,Pusztai L,Cristofanilli M

    更新日期:2007-02-01 00:00:00

  • Biology of metastasis.

    abstract::The acquisition by tumor cells of the ability to metastasize is the critical event in the clinical course of most human neoplastic disease. While metastasis plays a pivotal role in the ultimate success of failure of therapy, it is in fact a result of a more insidious malignant process termed tumor progression. It is t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860715)58:2+<550::aid-cncr2820

    authors: Frost P,Fidler IJ

    更新日期:1986-07-15 00:00:00

  • An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi.

    abstract:BACKGROUND:Recently, a 23-gene signature was developed to produce a melanoma diagnostic score capable of differentiating malignant and benign melanocytic lesions. The primary objective of this study was to independently assess the ability of the gene signature to differentiate melanoma from benign nevi in clinically re...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30385

    authors: Clarke LE,Flake DD 2nd,Busam K,Cockerell C,Helm K,McNiff J,Reed J,Tschen J,Kim J,Barnhill R,Elenitsas R,Prieto VG,Nelson J,Kimbrell H,Kolquist KA,Brown KL,Warf MB,Roa BB,Wenstrup RJ

    更新日期:2017-02-15 00:00:00

  • Thallium-201 single photon emission computed tomography as an indicator of prognosis for patients with lung carcinoma.

    abstract:BACKGROUND:The uptake of thallium-201 (T1-201) in malignant tumors is associated with malignant potential (metastatic potential and proliferative activity). The grade of accumulation of T1-201 in malignant tumors may provide information regarding prognosis. METHODS:A T1-201 single photon emission computed tomography w...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19970715)80:2<198::aid-cnc

    authors: Takekawa H,Takaoka K,Tsukamoto E,Kanegae K,Miller F,Kawakami Y

    更新日期:1997-07-15 00:00:00

  • Prognostic significance of grading in lung adenocarcinoma.

    abstract:BACKGROUND:Although grading has prognostic significance for many tumor types, a prognostically significant grading system for lung adenocarcinoma has not yet been established. The aim of this study was to evaluate histologic characteristics included in tumor grading systems, establish optimal cutoff values that have th...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24831

    authors: Barletta JA,Yeap BY,Chirieac LR

    更新日期:2010-02-01 00:00:00

  • Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors.

    abstract:BACKGROUND:Gastrointestinal stromal tumors (GISTs) historically were grouped with leiomyosarcomas (LMSs) based on their morphologic similarities; however, recently, GIST was established unequivocally as a distinct type of sarcoma based on its molecular features and response to imatinib treatment. METHODS:To gain furth...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25594

    authors: Ylipää A,Hunt KK,Yang J,Lazar AJ,Torres KE,Lev DC,Nykter M,Pollock RE,Trent J,Zhang W

    更新日期:2011-01-15 00:00:00

  • Is the International Federation of Gynecology and Obstetrics staging system for cervical carcinoma able to predict survival in patients with cervical carcinoma?: an assessment of clinimetric properties.

    abstract:BACKGROUND:The objective of this article was to assess the clinimetric properties of the International Federation of Gynecology and Obstetrics (FIGO) staging system of cervical carcinoma to determine whether it is an adequate prognostic tool for the survival of patients with cervical carcinoma. METHODS:The FIGO stagin...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20010815)92:4<796::aid-cncr1385>

    authors: Kupets R,Covens A

    更新日期:2001-08-15 00:00:00

  • Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.

    abstract:BACKGROUND:In the current study, the authors investigated the incidence of moderate to severe chemotherapy-induced peripheral neuropathy (CIPN) for chemotherapy regimens commonly used in current clinical practice for the treatment of patients with early breast cancer. Patient-reported and clinician-assessed CIPN severi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32175

    authors: Nyrop KA,Deal AM,Reeder-Hayes KE,Shachar SS,Reeve BB,Basch E,Choi SK,Lee JT,Wood WA,Anders CK,Carey LA,Dees EC,Jolly TA,Kimmick GG,Karuturi MS,Reinbolt RE,Speca JC,Muss HB

    更新日期:2019-09-01 00:00:00

  • Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck.

    abstract::A bolus intravenous dose of 5-fluorouracil of 600 mg/M2 was added exactly 1 hour after methotrexate administration in an established combination program including bleomycin and cisplatin for advanced squamous cell cancer of the head and neck. Results were no better than those observed previously with the three drugs, ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860215)57:4<706::aid-cncr28205

    authors: Vogl SE,Komisar A,Kaplan BH,Engstrom PF,Kasule OH,Stolbach L,Lerner H,Muggia F

    更新日期:1986-02-15 00:00:00

  • Malignant peritoneal mesothelioma following radiotherapy for seminoma of the testis.

    abstract::The difficulties encountered in establishing a diagnosis of a malignant peritoneal mesothelioma are emphasized in a patient who developed the lesion 16 years after radiation therapy for a seminoma of the testis. Historically, histologically, electron microscopically, and by microincineration, there was no evidence of ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197909)44:3<914::aid-cncr2820440

    authors: Stock RJ,Fu YS,Carter JR

    更新日期:1979-09-01 00:00:00

  • Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies.

    abstract:BACKGROUND:Radiofrequency (RF) ablation is an increasingly applied technique. Promising results of hepatic RF ablation raised expectations of its capabilities for treatment of primary and secondary lung tumors. Because of different thermal and electrical properties of lung tissue, compared with liver tissue, a simple a...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/cncr.23882

    authors: Clasen S,Krober SM,Kosan B,Aebert H,Fend F,Bomches A,Claussen CD,Pereira PL

    更新日期:2008-12-01 00:00:00

  • Flow DNA analysis of primary bone tumors. Relationship between cellular DNA content and histopathologic classification.

    abstract::The cellular DNA content of 15 benign and 34 malignant primary bone tumors was analyzed by means of flow cytophotometry. All benign tumors except one of questionable histologic type exhibited a normal DNA content (diploid), whereas 23 of 34 malignant tumors showed an abnormal DNA content (aneuploid). Closer analysis r...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840101)53:1<129::aid-cncr28205

    authors: Kreicbergs A,Silvferswärd C,Tribukait B

    更新日期:1984-01-01 00:00:00

  • Association of Langerhans cell histiocytosis with malignant neoplasms.

    abstract:BACKGROUND:The association of Langerhans cell histiocytosis (LCH) with a malignant neoplasm is rare and generally has been the subject of isolated case reports. METHODS:A recent case of LCH seen at the University of Minnesota in combination with acute lymphoblastic leukemia led the authors to review their own charts f...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19930201)71:3<865::aid-cncr28207

    authors: Egeler RM,Neglia JP,Puccetti DM,Brennan CA,Nesbit ME

    更新日期:1993-02-01 00:00:00

  • Prostate-specific antigen levels from completely sectioned, clinically benign, whole prostates.

    abstract::Clinically benign whole, untrimmed prostates and pelvic lymph nodes were obtained from 105 patients at autopsy. All 105 patients had premortem serum from which prostate-specific antigen (PSA) levels were obtained. Sixty-eight did not have carcinoma of the prostate (CAP), 28 had CAP less than 1 ml and 9 had CAP larger ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19911001)68:7<1592::aid-cncr2820

    authors: Brawn PN,Speights VO,Kuhl D,Riggs M,Spiekerman AM,McCord RG,Coffield KS,Stewart DT,Lind ML

    更新日期:1991-10-01 00:00:00

  • Abnormal vitamin B6 status in childhood leukemia.

    abstract::Vitamin B6 is involved in many biological processes of potential relevance to carcinogenesis and tumor growth, including DNA synthesis and maintenance of immunocompetence, yet very little information exists on B6 nutritional status in childhood leukemia. Using a radioenzymatic assay, the authors measured plasma pyrido...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19901201)66:11<2421::aid-cncr282

    authors: Pais RC,Vanous E,Hollins B,Faraj BA,Davis R,Camp VM,Ragab AH

    更新日期:1990-12-01 00:00:00

  • Comparative tumor localization of whole immunoglobulin G anticarcinoembryonic antigen monoclonal antibodies IMMU-4 and IMMU-4 F(ab')2 in colorectal cancer patients.

    abstract:BACKGROUND:Previous studies in the literature have suggested that radiolabeled F(ab')2 fragments might be superior to whole immunoglobulin G (IgG) for imaging and therapy of cancer because of their greater penetration in tumors. To test this hypothesis, the authors compared tumor and normal tissue uptake along with pla...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19940201)73:3+<850::aid-cncr2820

    authors: Murray JL,Rosenblum MG,Zhang HZ,Podoloff DA,Kasi LP,Curley SA,Chan JC,Roh M,Hohn DC,Brewer H

    更新日期:1994-02-01 00:00:00

  • Parathyroid hormone-related protein is an independent prognostic factor for renal cell carcinoma.

    abstract:BACKGROUND:Parathyroid hormone-related protein (PTHrP) has been shown to be the principal cause of humoral hypercalcemia associated with renal cell carcinoma (RCC). Recent studies have demonstrated that the amino-terminal region of PTHrP has growth factor-like activities, suggesting it may play a role in the developmen...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19990915)86:6<1028::aid-cn

    authors: Iwamura M,Wu W,Muramoto M,Ohori M,Egawa S,Uchida T,Baba S

    更新日期:1999-09-15 00:00:00

  • Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance.

    abstract:BACKGROUND:Active surveillance (AS) with deferred treatment is an established management option for patients with prostate cancer and favorable clinical parameters. The impact of repeat biopsy after diagnosis was examined in a cohort of men with prostate cancer on AS. METHODS:In all, 186 men with prostate cancer with ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23575

    authors: Al Otaibi M,Ross P,Fahmy N,Jeyaganth S,Trottier H,Sircar K,Bégin LR,Souhami L,Kassouf W,Aprikian A,Tanguay S

    更新日期:2008-07-15 00:00:00

  • Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival.

    abstract:BACKGROUND:Radiotherapy (RT) has been a risk factor for development of soft tissue sarcomas (STS). The objective of the current study was to quantify the risk of STS after RT and surgery for breast cancer (BCa), assess time trends, and compare long-term survival of patients with RT-associated and non-RT-associated angi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24462

    authors: Mery CM,George S,Bertagnolli MM,Raut CP

    更新日期:2009-09-15 00:00:00

  • Chronic lymphocytic leukemia. Immunologic markers and functional properties of the leukemic cells.

    abstract::In 230 cases of chronic lymphocytic leukemia (CLL), marker analysis was performed with rosette techniques and a panel of xeno-antisera. A monoclonal B-cell proliferation was found in the majority of cases (94%). In most cases, the B-cells carried IgM, with or without IgD. Cytoplasmic immunoglobulin-inclusion bodies we...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19821215)50:12<2826::aid-cncr282

    authors: van der Reijden HJ,van der Gaag R,Pinkster J,Rümke HC,van't Veer MB,Melief CJ,von dem Borne AE

    更新日期:1982-12-15 00:00:00

  • Closing the divide: diverse populations and cancer survivorship.

    abstract::Currently, there is a "divide" between cancer survivorship initiatives and minority participation. The level of participation is nearly nonexistent in many cancer support and control initiatives. Cancer survivorship resources that facilitate access to treatment, psychosocial interventions, clinical trials, and researc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21251

    authors: Guidry JJ,Torrence W,Herbelin S

    更新日期:2005-12-01 00:00:00

  • A phase II study of bortezomib in the treatment of metastatic malignant melanoma.

    abstract:BACKGROUND:Bortezomib is a proteasome inhibitor with manageable clinical toxicity and laboratory evidence of anti-melanoma activity. Therefore, it was considered for clinical testing in patients with metastatic melanoma. METHODS:Patients with metastatic melanoma and adequate hematologic, renal, and hepatic function we...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/cncr.21108

    authors: Markovic SN,Geyer SM,Dawkins F,Sharfman W,Albertini M,Maples W,Fracasso PM,Fitch T,Lorusso P,Adjei AA,Erlichman C

    更新日期:2005-06-15 00:00:00

  • Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapies.

    abstract::Central nervous system (CNS) recurrence continues to be a significant complication in the treatment of adult patients with acute lymphoblastic leukemia (ALL). Preventing CNS recurrence has been a therapeutic challenge and has not been addressed critically in many clinical trials. Adult studies modeled on childhood ALL...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.25008

    authors: Jabbour E,Thomas D,Cortes J,Kantarjian HM,O'Brien S

    更新日期:2010-05-15 00:00:00

  • Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia.

    abstract::Sixty-four adult patients with refractory acute lymphocytic leukemia (ALL) received salvage therapy with the vincristine, doxorubicin (Adriamycin, Adria Laboratories, Columbus, OH), and dexamethasone (VAD) regimen consisting of induction chemotherapy with the three agents followed by multiple-agent maintenance therapy...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890701)64:1<16::aid-cncr282064

    authors: Kantarjian HM,Walters RS,Keating MJ,Barlogie B,McCredie KB,Freireich EJ

    更新日期:1989-07-01 00:00:00

  • Recruiting cancer patients to participate in motivating their relatives to quit smoking. A cancer control study of the Cancer and Leukemia Group B (CALGB 9072).

    abstract:BACKGROUND:A diagnosis of cancer provides a teachable moment in which a physician can counsel or teach the patient. The Cancer and Leukemia Group B hypothesized that this teachable moment could also be used to encourage counseling of the patients' relatives who smoke. The authors' first study sought to determine the fe...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/(sici)1097-0142(19970101)79:1<152::aid-cnc

    authors: Schilling A,Conaway MR,Wingate PJ,Atkins JN,Berkowitz IM,Clamon GH,DiFino SM,Vinciguerra V

    更新日期:1997-01-01 00:00:00

  • Fanconi anemia. Oxymetholone hepatic tumors, and chromosome aberrations associated with leukemic transition.

    abstract::Jaundice and hepatomegaly developed in a boy with Fanconi anemia after he had undergone treatment with oxymetholone for nine years. A liver scan showed patchy uptake consistent with the presence of space-occupying lesions. After oxymetholone treatment was stopped, the jaundice resolved, the liver size decreased, and t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800915)46:6<1401::aid-cncr2820

    authors: Obeid DA,Hill FG,Harnden D,Mann JR,Wood BS

    更新日期:1980-09-15 00:00:00

  • Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.

    abstract:BACKGROUND:The American Joint Committee on Cancer (AJCC) 7th edition introduced major changes in the staging of lung cancer, including the tumor (T), node (N), metastasis (M)-TNM-system and new stage/prognostic site-specific factors (SSFs), collected under the Collaborative Stage Version 2 (CSv2) Data Collection System...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29045

    authors: Chen VW,Ruiz BA,Hsieh MC,Wu XC,Ries LA,Lewis DR

    更新日期:2014-12-01 00:00:00